American Board of Obstetrics & Gynecology (ABOG) Qualifying Practice Exam

The recommendation to screen women aged 19-64 for HIV is grounded in the understanding that this age group can be at significant risk for HIV exposure. Public health guidelines, including those from the Centers for Disease Control and Prevention (CDC), advocate for routine HIV screening for individuals in this demographic due to the possibility of silent infections and the high potential for transmission if undiagnosed. Regular screening not only aids in early detection and treatment but also helps in reducing the overall incidence of HIV within the population.

Routine screening in this age group allows for an increased likelihood of identifying women who may be at risk due to various factors such as multiple sexual partners, inconsistent condom use, or a history of sexually transmitted infections. This proactive approach enables the provision of timely medical interventions and the promotion of safer practices.

In contrast, while other groups mentioned may have relevance in certain contexts, they do not reflect the broad, generalized recommendation for universal screening of HIV in a specific demographic as prominently as women aged 19-64. These recommendations are tailored based on epidemiological data suggesting higher rates of infection within this age bracket, as well as the benefits of early diagnosis and treatment.